{"id":"https://openalex.org/W2145394548","doi":"https://doi.org/10.1093/toxsci/kft223","title":"A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans","display_name":"A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W2145394548","doi":"https://doi.org/10.1093/toxsci/kft223","mag":"2145394548","pmid":"https://pubmed.ncbi.nlm.nih.gov/24085192"},"language":"en","primary_location":{"id":"doi:10.1093/toxsci/kft223","doi":"https://doi.org/10.1093/toxsci/kft223","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kft223","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145394548"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083698383","display_name":"Frida Gustafsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Frida Gustafsson","raw_affiliation_strings":["* Global Safety Assessment and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"* Global Safety Assessment and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003537475","display_name":"Alison J. Foster","orcid":"https://orcid.org/0000-0002-5192-919X","observed_orcids":["https://orcid.org/0000-0002-5192-919X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison J. Foster","raw_affiliation_strings":["Global Safety Assessment and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Safety Assessment and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028711227","display_name":"Sunil Sarda","orcid":"https://orcid.org/0000-0002-1347-0904","observed_orcids":["https://orcid.org/0000-0002-1347-0904"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sunil Sarda","raw_affiliation_strings":["\u2020 Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom","#N#\u2020#N#Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"#N#\u2020#N#Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom#N#","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111777536","display_name":"Matthew H. Bridgland-Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew H. Bridgland-Taylor","raw_affiliation_strings":["\u2020 Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom","#N#\u2020#N#Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"#N#\u2020#N#Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom#N#","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028281331","display_name":"J. Gerry Kenna","orcid":"https://orcid.org/0000-0002-6927-8962","observed_orcids":["https://orcid.org/0000-0002-6927-8962"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Gerry Kenna","raw_affiliation_strings":["\u00a7AstraZeneca, Discovery Sciences, Macclesfield, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u00a7AstraZeneca, Discovery Sciences, Macclesfield, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083698383"],"corresponding_institution_ids":[],"apc_list":{"value":4671,"currency":"USD","value_usd":4671},"apc_paid":null,"fwci":5.4862,"has_fulltext":false,"cited_by_count":80,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97270498,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"137","issue":"1","first_page":"189","last_page":"211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6110000014305115},{"id":"https://openalex.org/keywords/human-cytochrome-p450","display_name":"human cytochrome P450","score":0.847000002861023},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6069999933242798},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.4830000102519989},{"id":"https://openalex.org/keywords/reactive-metabolites","display_name":"reactive metabolites","score":0.6389999985694885},{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.8209999799728394},{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":0.9940000176429749},{"id":"https://openalex.org/keywords/plasma-exposure","display_name":"plasma exposure","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6426182389259338},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.5979229211807251},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5880087018013},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5211113095283508},{"id":"https://openalex.org/C2992672570","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Liver cell","level":2,"score":0.5055551528930664},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.48019206523895264},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4418545663356781},{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.4378727972507477},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3752017617225647},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.36184781789779663},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1707935929298401},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10849389433860779},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.07447043061256409},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018675","descriptor_name":"Toxicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/toxsci/kft223","doi":"https://doi.org/10.1093/toxsci/kft223","is_oa":false,"landing_page_url":"https://doi.org/10.1093/toxsci/kft223","pdf_url":null,"source":{"id":"https://openalex.org/S186282544","display_name":"Toxicological Sciences","issn_l":"1096-0929","issn":["1096-0929","1096-6080"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological Sciences","raw_type":"journal-article"},{"id":"pmid:24085192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24085192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicological sciences : an official journal of the Society of Toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320330399","display_name":"Nestec","ror":"https://ror.org/014x0er85"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1523813923","https://openalex.org/W1703321169","https://openalex.org/W1966612438","https://openalex.org/W1971763588","https://openalex.org/W1977122152","https://openalex.org/W1979708281","https://openalex.org/W1983060510","https://openalex.org/W1989343195","https://openalex.org/W1992890364","https://openalex.org/W1996935441","https://openalex.org/W1998101020","https://openalex.org/W1999587831","https://openalex.org/W2021312311","https://openalex.org/W2022430282","https://openalex.org/W2023922443","https://openalex.org/W2029818729","https://openalex.org/W2035508730","https://openalex.org/W2040348660","https://openalex.org/W2041417337","https://openalex.org/W2048125031","https://openalex.org/W2052919116","https://openalex.org/W2053595725","https://openalex.org/W2061788598","https://openalex.org/W2068532562","https://openalex.org/W2074577842","https://openalex.org/W2087561463","https://openalex.org/W2095640407","https://openalex.org/W2096483572","https://openalex.org/W2114312904","https://openalex.org/W2127284788","https://openalex.org/W2134837921","https://openalex.org/W2141081902","https://openalex.org/W2142462614","https://openalex.org/W2143984053","https://openalex.org/W2146316557","https://openalex.org/W2146592372","https://openalex.org/W2166456560","https://openalex.org/W2171300878","https://openalex.org/W2314375540","https://openalex.org/W2740285087"],"related_works":["https://openalex.org/W2166456560","https://openalex.org/W917542033","https://openalex.org/W2218551807","https://openalex.org/W1773543011","https://openalex.org/W2074516036","https://openalex.org/W2580643590","https://openalex.org/W2065720731","https://openalex.org/W2766507275","https://openalex.org/W1837043810","https://openalex.org/W2142462614"],"abstract_inverted_index":{"Drug":[0],"toxicity":[1,132,158,196,218],"to":[2,57,70,86,161,166,176,183,219,236,249],"T-antigen-immortalized":[3],"human":[4,16,88,114,125,201,245],"liver":[5,89,115,126,202,239],"epithelial":[6],"(THLE)":[7],"cells":[8,98],"stably":[9],"transfected":[10,99],"with":[11,73,100,233],"plasmid":[12,28],"vectors":[13],"that":[14,139,153,215,242],"encoded":[15],"cytochrome":[17],"P450s":[18,165],"1A2,":[19],"2C9,":[20],"2C19,":[21],"2D6,":[22],"or":[23,25,142],"3A4,":[24],"an":[26],"empty":[27],"vector":[29],"(THLE-Null),":[30],"was":[31,55,174],"investigated.":[32],"An":[33,117],"automated":[34],"screening":[35],"platform,":[36],"which":[37,123,173],"included":[38,140,171],"1%":[39,143],"dimethyl":[40],"sulfoxide":[41],"(DMSO)":[42],"vehicle,":[43],"2.7%":[44],"bovine":[45,147],"serum":[46],"in":[47,97,105,185],"the":[48,59,151],"culture":[49],"medium,":[50],"and":[51,180,221,241],"assessed":[52],"3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium":[53],"reduction,":[54],"used":[56],"evaluate":[58],"cytotoxicity":[60,69],"of":[61,79,109,122,150,217,231,244],"103":[62],"drugs":[63,67,81,92,111,152,170,232],"after":[64],"24h.":[65],"Twenty-two":[66],"caused":[68,113,124],"THLE-Null":[71,106,220],"cells,":[72],"EC\u2085\u2080":[74,95],"\u2264":[75],"200":[76],"\u03bcM;":[77],"21":[78],"these":[80,110],"(95%)":[82],"have":[83],"been":[84],"reported":[85,209],"cause":[87,200,237],"injury.":[90,116],"Eleven":[91],"exhibited":[93,128,154,192],"lower":[94],"values":[96],"CYP3A4":[101],"(THLE-3A4":[102],"cells)":[103],"than":[104],"cells;":[107],"10":[108],"(91%)":[112],"additional":[118],"8":[119],"drugs,":[120],"all":[121],"injury,":[127],"potentiated":[129,155],"THLE-3A4":[130,156,186,222],"cell":[131,157,195,223],"when":[133],"evaluated":[134],"using":[135],"a":[136],"manual":[137],"protocol":[138],"0.2%":[141],"DMSO,":[144],"but":[145,197],"not":[146,199],"serum.":[148],"Fourteen":[149],"are":[159],"known":[160],"be":[162],"metabolized":[163],"by":[164],"reactive":[167],"intermediates.":[168],"These":[169,212],"troglitazone,":[172],"shown":[175],"undergo":[177],"metabolic":[178],"bioactivation":[179],"covalent":[181],"binding":[182],"proteins":[184],"cells.":[187],"A":[188],"single":[189],"drug":[190,205,226],"(rimonabant)":[191],"marked":[193],"THLE":[194],"did":[198],"injury;":[203],"this":[204],"had":[206],"very":[207],"low":[208],"plasma":[210],"exposure.":[211],"results":[213],"indicate":[214],"evaluation":[216],"lines":[224],"during":[225],"discovery":[227],"may":[228],"aid":[229],"selection":[230],"reduced":[234],"propensity":[235],"drug-induced":[238],"injury":[240],"consideration":[243],"exposure":[246],"is":[247],"required":[248],"enhance":[250],"data":[251],"interpretation.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145394548","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
